Pernix Therapeutics downgraded to Neutral from Buy at Guggenheim

theflyonthewall.com

Guggenheim downgraded Pernix following the Q3 miss and lowered guidance. Note that Cantor upgraded shares to Hold this morning.

View Comments (0)